You are here: Home - Investing - Experienced Investor - News -

BLOG: Five ways to future-proof your ISA portfolio

Written by: Juliet Schooling Latter
We are living in such fast-changing times that it can be difficult to keep up.

The incredible advances within technology, medicine and the environment are transforming everyone’s lives. For example, Apple only launched the first iPhone 15 years ago – but millions are now sold every year. Can you even imagine life without a smartphone?

Of course, these remarkable advances pose a dilemma for investors: How do they help ensure their chosen holdings can stand the test of time?

Here, we highlight five interesting funds that may help future-proof your ISA portfolio with theme and fund exposures that are expected to flourish in the coming years.

Guinness Global Innovators fund

As the name suggests, this fund is all about finding, and investing in, innovative and disruptive businesses which are changing the world in which we live. The managers have created an investment universe by identifying nine innovation themes from which they pick the highest quality, fastest growing and best value stocks.

These themes are advanced healthcare; artificial intelligence and big data; clean energy and sustainability; cloud computing; internet, media and entertainment; mobile technology and the internet of things; next generation consumer; payments and FinTech; robotics and automation.

VT Gravis Clean Energy Income fund

Renewable energy is an important theme and this fund’s aim is to capitalise from the move into this area, while generating an attractive income and modest capital growth. The fund, which aims to deliver a 4.5% dividend yield after charges, invests in various assets that are involved in the clean power generation sector.

This includes profitable companies that derive a significant proportion of revenue from increasing the efficiency of – and reducing the pollution from – traditional power generation.

The portfolio currently has 42% invested in wind, 31.3% in solar, and 7.7% in hydro.

The largest stock weighting of 7.4% is currently in Greencoat UK Wind, which invests in operating UK wind farms.

AXA Framlington Global Technology fund

This fund aims to provide long-term capital growth by investing in technology companies from around the world. A look at its holdings illustrates the point: Alphabet, Apple and Amazon are among the 10 biggest positions in the portfolio. The fund is managed by industry veteran Jeremy Gleeson. As well as being at the helm of this portfolio since 2007, he’s been involved in the technology sector for almost 25 years.

Looking ahead, the manager expects to see more robust spending on cybersecurity as companies face more threats to access their data and systems.

“Firewalls, email protection, cloud-based security and vulnerability management are all important aspects of a holistic approach to cybersecurity and we have several investments across these areas,” he said.

Schroder Digital Infrastructure fund

No-one can argue that we’re undergoing a digital transformation and the demand for data has increased exponentially in recent years. Despite this, our digital infrastructure is way behind where it needs to be: half the global population still don’t even have access to the internet.

That’s where this fund comes into play. Its philosophy is simple: technological advances are driving massive demand for data and therefore digital infrastructure. Digital transformation is impacting every industry and access to the internet is now ‘mission critical’ for society – our whole economy is dependent on it. Therefore, digital infrastructure is critical for future economic growth.

Polar Capital Global Healthcare Trust

There have been some incredible advances in healthcare over recent years and this fund looks for the best growth opportunities within these industries. The holdings will generally hail from four sub-sectors: pharmaceuticals, biotechnology, medical technology, and healthcare services.

The managers can buy into everything from innovative small-cap biotechnology stocks to global pharmaceutical giants. The main criteria is having powerful growth stories that are shaping the world, but large-cap, high quality healthcare holdings will dominate. This is illustrated by examining the top 10 positions. This list includes Johnson & Johnson, AstraZeneca, Bristol Myers Squibb and Sanofi.

Juliet Schooling Latter is research director at FundCalibre

There are 0 Comment(s)

If you wish to comment without signing in, click your cursor in the top box and tick the 'Sign in as a guest' box at the bottom.

Seven ways to get help with energy bills this winter

We knew today’s announcement was going to be painful, but it’s still a shock to the system. When this kick...

Flight cancelled or delayed? Your rights explained

With no sign of the problems in UK aviation easing over the peak summer period, many will worry whether holida...

Rail strikes: Your travel and refund rights

Thousands of railway workers will strike across three days this week, grinding much of the transport system to...

What will happen if rates change

How your finances will be impacted by a rise in interest rates.

Regular Savings Calculator

Small regular contributions can build up nicely over time.

Online Savings Calculator

Work out how your online savings can build over time.

DIY investors: 10 common mistakes to avoid

For those without the help and experience of an adviser, here are 10 common DIY investor mistakes to avoid.

Mortgage down-valuations: Tips to avoid pulling out of a house sale

Down-valuations are on the rise. So, what does it mean for home buyers, and what can you do?

Five tips for surviving a bear market mauling

The S&P 500 has slipped into bear market territory and for UK investors, the FTSE 250 is also on the edge. Her...

Money Tips of the Week